FASLG and Venous thrombosis: Dipyridamole, which is known to potentiate adenosine receptor signaling by increasing extracellular concentrations of adenosine and interfering with the breakdown of adenosine 3′,5′-monophosphate (cAMP), also suppresses aPL antibody–mediated NETosis and mitigates venous thrombosis in mice (64).